# A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile

> **NCT05926804** · NA · RECRUITING · sponsor: **Miguel O'Ryan Gallardo** · enrollment: 500 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Lansoprazole
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT05926804
- **Lead sponsor:** Miguel O'Ryan Gallardo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-02
- **Primary completion:** 2026-10
- **Final completion:** 2027-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926804, "A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05926804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
